Canopy Growth Corp Net Income (Loss) Attributable to Redeemable Noncontrolling Interest
Canopy Growth Corp (CGC) reported Net Income (Loss) Attributable to Redeemable Noncontrolling Interest of CAD 0 for the 12-month period ending 2025-03-31, per its 10-K filed 2025-05-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest · last filed 2025-05-30
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2024-03-31 was 0.00 CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2023-12-31 was 0.00 CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2023-09-30 was -14.79M CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2023-06-30 was -3.74M CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for fiscal 2025 was 0.00 CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for fiscal 2024 was -18.53M CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for fiscal 2023 was -29.54M CAD.
- Canopy Growth Corp net income (loss) attributable to redeemable noncontrolling interest for fiscal 2022 was -19.32M CAD.
| Period end | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 CAD 10-K · filed 2025-05-30 | |||||||
| 2024-03-31 | 0.00 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | 0.00 CAD derived: sum of 2 quarters · filed 2025-05-30 | -14.79M CAD derived: sum of 3 quarters · filed 2025-05-30 | -18.53M CAD 10-K · filed 2025-05-30 | ||||
| 2023-12-31 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-09 | -14.79M CAD derived: sum of 2 quarters · filed 2024-02-09 | -18.53M CAD 10-Q · filed 2024-02-09 | -26.05M CAD derived: sum of 4 quarters · filed 2025-05-30 | ||||
| 2023-09-30 | -14.79M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | -18.53M CAD 10-Q · filed 2023-11-09 | -26.05M CAD derived: sum of 3 quarters · filed 2025-05-30 | -30.97M CAD derived: sum of 4 quarters · filed 2025-05-30 | ||||
| 2023-06-30 | -3.74M CAD 10-Q · filed 2023-08-09 | -11.27M CAD derived: sum of 2 quarters · filed 2025-05-30 | -16.18M CAD derived: sum of 3 quarters · filed 2025-05-30 | -27.98M CAD derived: sum of 4 quarters · filed 2025-05-30 | ||||
| 2023-03-31 | -7.53M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | -12.44M CAD derived: sum of 2 quarters · filed 2025-05-30 | -24.24M CAD derived: sum of 3 quarters · filed 2025-05-30 | -29.54M CAD 10-K · filed 2025-05-30 | ||||
| 2022-12-31 | -4.91M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-09 | -16.71M CAD derived: sum of 2 quarters · filed 2024-02-09 | -22.02M CAD 10-Q · filed 2024-02-09 | -17.81M CAD 10-Q · filed 2023-02-09 | -28.23M CAD derived: sum of 4 quarters · filed 2024-05-30 | |||
| 2022-09-30 | -11.80M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | -17.10M CAD 10-Q · filed 2023-11-09 | -12.67M CAD 10-Q · filed 2022-11-09 | -23.32M CAD derived: sum of 3 quarters · filed 2024-05-30 | -28.68M CAD derived: sum of 4 quarters · filed 2024-05-30 | |||
| 2022-06-30 | -5.31M CAD 10-Q · filed 2023-08-09 | -4.41M CAD 10-Q · filed 2022-08-09 | -11.52M CAD derived: sum of 2 quarters · filed 2024-05-30 | -16.89M CAD derived: sum of 3 quarters · filed 2024-05-30 | -22.16M CAD derived: sum of 4 quarters · filed 2024-05-30 | |||
| 2022-03-31 | -6.22M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30 | -11.58M CAD derived: sum of 2 quarters · filed 2024-05-30 | -16.85M CAD derived: sum of 3 quarters · filed 2024-05-30 | -19.32M CAD 10-K · filed 2024-05-30 | -17.10M CAD 10-K · filed 2022-05-31 | |||
| 2021-12-31 | -5.36M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | -10.64M CAD derived: sum of 2 quarters · filed 2023-02-09 | -13.10M CAD 10-Q · filed 2023-02-09 | -21.30M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-09-30 | -5.27M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | -7.74M CAD 10-Q · filed 2022-11-09 | 7.74M CAD 10-Q · filed 2021-11-08 | -15.93M CAD derived: sum of 3 quarters · filed 2023-06-22 | -16.39M CAD derived: sum of 4 quarters · filed 2023-06-22 | |||
| 2021-06-30 | -2.46M CAD 10-Q · filed 2022-08-09 | -10.66M CAD derived: sum of 2 quarters · filed 2023-06-22 | -11.12M CAD derived: sum of 3 quarters · filed 2023-06-22 | -9.88M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-03-31 | -8.20M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | -8.65M CAD derived: sum of 2 quarters · filed 2023-06-22 | -7.41M CAD derived: sum of 3 quarters · filed 2023-06-22 | -18.08M CAD 10-K · filed 2023-06-22 | ||||
| 2020-12-31 | -455.00K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | 783.00K CAD derived: sum of 2 quarters · filed 2022-02-09 | -9.88M CAD 10-Q · filed 2022-02-09 | -7.08M CAD derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | 1.24M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | -9.43M CAD 10-Q · filed 2021-11-08 | -6.62M CAD derived: sum of 3 quarters · filed 2022-05-31 | |||||
| 2020-06-30 | -10.66M CAD 10-Q · filed 2021-08-06 | -7.86M CAD derived: sum of 2 quarters · filed 2022-05-31 | ||||||
| 2020-03-31 | 2.81M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | 6.49M CAD 10-K · filed 2022-05-31 | ||||||
| 2019-12-31 | 3.68M CAD 10-Q · filed 2021-02-09 | |||||||
| 2019-03-31 | 2.88M CAD 10-K · filed 2021-06-01 | |||||||
| 2018-03-31 | -5.47M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |